Definitive Research Development vs Total Revenue Analysis

DH Stock

USD 5.55 0.11 2.02%

Definitive Healthcare financial indicator trend analysis is much more than just examining Definitive Healthcare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Definitive Healthcare is a good investment. Please check the relationship between Definitive Healthcare Research Development and its Total Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Definitive Healthcare Research Development account and Total Revenue. At this time, the significance of the direction appears to have totally related.

The correlation between Definitive Healthcare's Research Development and Total Revenue is 0.99. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Definitive Healthcare Corp, assuming nothing else is changed. The correlation between historical values of Definitive Healthcare's Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Definitive Healthcare Corp are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Definitive Healthcare's Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Definitive Healthcare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Definitive Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Definitive Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

The current Selling General Administrative is estimated to decrease to about 35.5 M. The Definitive Healthcare's current Tax Provision is estimated to increase to about (31 M)

	2022	2023	2024	2025 (projected)
Interest Expense	8.4M	15.2M	13.7M	16.7M
Depreciation And Amortization	56.9M	51.8M	59.5M	57.6M

Interest Expense Depreciation And Amortization

Definitive Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab
Total Assets		-0.92	0.92	0.77	-0.9	0.93	-0.9	0.75	0.88	-0.9	-0.32	0.7	0.85	-0.58	0.88	0.91	-0.9	0.92	0.84	-0.42	-0.92	-0.85	0.96	0.33	0.91	0.9
Short Long Term Debt Total	-0.92		-0.96	-0.92	0.98	-0.99	0.97	-0.89	-0.96	0.93	0.55	-0.77	-0.83	0.73	-0.97	-0.95	1.0	-0.98	-0.94	0.59	0.99	0.8	-0.88	-0.13	-0.91	-0.95
Other Current Liab	0.92	-0.96		0.84	-0.95	0.94	-0.92	0.75	0.88	-0.97	-0.42	0.72	0.92	-0.66	0.89	0.88	-0.95	0.96	0.84	-0.53	-0.94	-0.76	0.87	0.18	0.82	0.9
Total Current Liabilities	0.77	-0.92	0.84		-0.93	0.91	-0.85	0.96	0.97	-0.78	-0.74	0.89	0.64	-0.81	0.93	0.92	-0.93	0.9	0.98	-0.69	-0.9	-0.77	0.82	-0.1	0.84	0.96
Total Stockholder Equity	-0.9	0.98	-0.95	-0.93		-0.99	0.94	-0.87	-0.95	0.91	0.65	-0.84	-0.81	0.81	-0.98	-0.94	0.98	-0.95	-0.93	0.68	0.98	0.85	-0.91	-0.01	-0.87	-0.97
Other Liab	0.93	-0.99	0.94	0.91	-0.99		-0.97	0.87	0.96	-0.92	-0.58	0.8	0.82	-0.75	0.99	0.96	-0.99	0.96	0.94	-0.61	-0.99	-0.85	0.92	0.1	0.92	0.95
Net Tangible Assets	-0.9	0.97	-0.92	-0.85	0.94	-0.97		-0.82	-0.92	0.96	0.45	-0.75	-0.88	0.59	-0.92	-0.95	0.96	-0.98	-0.89	0.42	0.99	0.84	-0.84	-0.28	-0.93	-0.88
Property Plant And Equipment Net	0.75	-0.89	0.75	0.96	-0.87	0.87	-0.82		0.95	-0.71	-0.65	0.78	0.53	-0.71	0.9	0.92	-0.91	0.86	0.98	-0.58	-0.87	-0.7	0.78	0.02	0.89	0.92
Current Deferred Revenue	0.88	-0.96	0.88	0.97	-0.95	0.96	-0.92	0.95		-0.86	-0.61	0.88	0.73	-0.72	0.95	0.99	-0.96	0.95	0.99	-0.57	-0.95	-0.86	0.9	0.11	0.95	0.98
Net Debt	-0.9	0.93	-0.97	-0.78	0.91	-0.92	0.96	-0.71	-0.86		0.32	-0.71	-0.97	0.52	-0.84	-0.89	0.92	-0.97	-0.81	0.37	0.94	0.79	-0.82	-0.34	-0.85	-0.84
Retained Earnings	-0.32	0.55	-0.42	-0.74	0.65	-0.58	0.45	-0.65	-0.61	0.32		-0.74	-0.18	0.91	-0.69	-0.51	0.57	-0.44	-0.65	0.91	0.53	0.52	-0.49	0.7	-0.38	-0.66
Accounts Payable	0.7	-0.77	0.72	0.89	-0.84	0.8	-0.75	0.78	0.88	-0.71	-0.74		0.63	-0.73	0.81	0.85	-0.78	0.79	0.87	-0.61	-0.78	-0.91	0.81	-0.12	0.76	0.89
Cash	0.85	-0.83	0.92	0.64	-0.81	0.82	-0.88	0.53	0.73	-0.97	-0.18	0.63		-0.39	0.71	0.79	-0.81	0.89	0.67	-0.25	-0.84	-0.76	0.76	0.4	0.75	0.73
Non Current Assets Total	-0.58	0.73	-0.66	-0.81	0.81	-0.75	0.59	-0.71	-0.72	0.52	0.91	-0.73	-0.39		-0.84	-0.63	0.73	-0.61	-0.74	0.98	0.69	0.6	-0.71	0.56	-0.51	-0.8
Non Currrent Assets Other	0.88	-0.97	0.89	0.93	-0.98	0.99	-0.92	0.9	0.95	-0.84	-0.69	0.81	0.71	-0.84		0.93	-0.97	0.91	0.94	-0.71	-0.97	-0.82	0.9	-0.04	0.88	0.96
Other Assets	0.91	-0.95	0.88	0.92	-0.94	0.96	-0.95	0.92	0.99	-0.89	-0.51	0.85	0.79	-0.63	0.93		-0.96	0.97	0.97	-0.46	-0.96	-0.88	0.9	0.24	0.98	0.96
Long Term Debt	-0.9	1.0	-0.95	-0.93	0.98	-0.99	0.96	-0.91	-0.96	0.92	0.57	-0.78	-0.81	0.73	-0.97	-0.96		-0.98	-0.95	0.59	0.99	0.79	-0.88	-0.12	-0.92	-0.95
Cash And Short Term Investments	0.92	-0.98	0.96	0.9	-0.95	0.96	-0.98	0.86	0.95	-0.97	-0.44	0.79	0.89	-0.61	0.91	0.97	-0.98		0.93	-0.45	-0.98	-0.83	0.87	0.27	0.93	0.93
Net Receivables	0.84	-0.94	0.84	0.98	-0.93	0.94	-0.89	0.98	0.99	-0.81	-0.65	0.87	0.67	-0.74	0.94	0.97	-0.95	0.93		-0.59	-0.93	-0.82	0.87	0.05	0.93	0.97
Good Will	-0.42	0.59	-0.53	-0.69	0.68	-0.61	0.42	-0.58	-0.57	0.37	0.91	-0.61	-0.25	0.98	-0.71	-0.46	0.59	-0.45	-0.59		0.54	0.43	-0.56	0.71	-0.32	-0.66
Common Stock Total Equity	-0.92	0.99	-0.94	-0.9	0.98	-0.99	0.99	-0.87	-0.95	0.94	0.53	-0.78	-0.84	0.69	-0.97	-0.96	0.99	-0.98	-0.93	0.54		0.83	-0.89	-0.17	-0.93	-0.94
Common Stock Shares Outstanding	-0.85	0.8	-0.76	-0.77	0.85	-0.85	0.84	-0.7	-0.86	0.79	0.52	-0.91	-0.76	0.6	-0.82	-0.88	0.79	-0.83	-0.82	0.43	0.83		-0.9	-0.16	-0.86	-0.87
Non Current Liabilities Total	0.96	-0.88	0.87	0.82	-0.91	0.92	-0.84	0.78	0.9	-0.82	-0.49	0.81	0.76	-0.71	0.9	0.9	-0.88	0.87	0.87	-0.56	-0.89	-0.9		0.14	0.88	0.94
Inventory	0.33	-0.13	0.18	-0.1	-0.01	0.1	-0.28	0.02	0.11	-0.34	0.7	-0.12	0.4	0.56	-0.04	0.24	-0.12	0.27	0.05	0.71	-0.17	-0.16	0.14		0.39	0.01
Other Current Assets	0.91	-0.91	0.82	0.84	-0.87	0.92	-0.93	0.89	0.95	-0.85	-0.38	0.76	0.75	-0.51	0.88	0.98	-0.92	0.93	0.93	-0.32	-0.93	-0.86	0.88	0.39		0.9
Total Liab	0.9	-0.95	0.9	0.96	-0.97	0.95	-0.88	0.92	0.98	-0.84	-0.66	0.89	0.73	-0.8	0.96	0.96	-0.95	0.93	0.97	-0.66	-0.94	-0.87	0.94	0.01	0.9

Click cells to compare fundamentals

Definitive Healthcare Account Relationship Matchups

Definitive Healthcare fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.7B	2.1B	2.1B	1.8B	2.1B	2.1B
Short Long Term Debt Total	461.9M	270.7M	275.8M	267.9M	241.1M	274.5M
Other Current Liab	16.1M	26.2M	21.7M	21.9M	25.2M	22.7M
Total Current Liabilities	88.7M	117.8M	132.5M	170.7M	196.3M	127.5M
Total Stockholder Equity	1.2B	873.2M	952.1M	861.4M	775.2M	815.8M
Property Plant And Equipment Net	3.2M	5.1M	14.1M	14.1M	16.2M	8.6M
Current Deferred Revenue	61.1M	83.6M	99.7M	97.4M	112.0M	85.3M
Net Debt	437.1M	(116.8M)	128.9M	137.0M	123.3M	162.7M
Retained Earnings	(109.9M)	(17.7M)	(23.7M)	(227.5M)	(204.7M)	(194.5M)
Accounts Payable	5.7M	4.7M	3.9M	5.8M	6.7M	4.9M
Cash	24.8M	387.5M	146.9M	131.0M	150.6M	153.7M
Non Current Assets Total	1.7B	1.7B	1.7B	1.4B	1.3B	1.3B
Non Currrent Assets Other	472K	12.6M	16.3M	19.2M	22.1M	23.2M
Other Assets	6.6M	12.8M	16.4M	13.5M	15.5M	11.5M
Long Term Debt	457.2M	263.8M	255.8M	242.6M	218.3M	264.7M
Cash And Short Term Investments	24.8M	387.5M	331.9M	308.1M	354.3M	233.4M
Net Receivables	33.1M	43.3M	58.8M	59.2M	68.1M	48.3M
Liabilities And Stockholders Equity	1.7B	2.1B	2.1B	1.8B	2.1B	2.1B
Non Current Liabilities Total	461.1M	494.9M	501.3M	456.0M	524.5M	516.6M
Other Current Assets	6.0M	13.4M	23.1M	13.1M	15.1M	12.6M
Total Liab	549.8M	612.7M	633.8M	626.7M	720.7M	644.1M
Net Invested Capital	1.7B	1.1B	1.2B	1.1B	1.0B	1.1B
Property Plant And Equipment Gross	3.2M	9.7M	14.1M	20.0M	23.0M	24.2M
Short Long Term Debt	4.7M	6.9M	8.6M	13.8M	15.8M	8.4M
Total Current Assets	63.8M	451.6M	413.7M	380.4M	437.5M	296.1M
Accumulated Other Comprehensive Income	(131K)	62K	3.7M	2.1M	2.4M	1.3M
Capital Stock	1.3B	97K	105K	117K	105.3K	100.0K
Net Working Capital	(24.9M)	333.8M	281.2M	223.2M	256.7M	171.5M
Short Term Debt	(50.9M)	6.9M	11.6M	16.0M	18.4M	19.3M
Intangible Assets	410.2M	352.5M	350.7M	323.1M	290.8M	301.3M
Common Stock	1.3B	97K	105K	117K	105.3K	100.0K

Currently Active Assets on Macroaxis

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications
DIA	SPDR Dow Jones
SPY	SPDR SP 500

How To Invest In Definitive

Details

Is Definitive Stock a good investment?

Details

What is Definitive Healthcare's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.09)

Revenue Per Share

2.187

Quarterly Revenue Growth

(0.04)

Return On Assets

(0.01)

Return On Equity

(0.55)

The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Definitive Research Development vs Total Revenue Analysis

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

Correlation Coefficient

Research Development

Total Revenue

Definitive Healthcare fundamental ratios Correlations

Definitive Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Definitive Healthcare fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Common Stock Total Equity	+ 0.99	Short Long Term Debt Total
Non Currrent Assets Other	+ 0.99	Other Liab
Common Stock Total Equity	+ 0.99	Net Tangible Assets
Other Assets	+ 0.99	Current Deferred Revenue
Net Receivables	+ 0.99	Current Deferred Revenue

Common Stock Total Equity	- 0.99	Other Liab
Long Term Debt	- 0.99	Other Liab
Other Liab	- 0.99	Total Stockholder Equity
Other Liab	- 0.99	Short Long Term Debt Total
Common Stock Total Equity	- 0.98	Cash And Short Term Investments
Cash And Short Term Investments	- 0.98	Long Term Debt